Medical emergency?Emergency? Call 911. Nearest emergency roomsNearest ERs

Brand-name prescription medicine

Axycis

Generic name: Cisplatin

FDA application holder: Avyxa Holdings, LLC.

Official data, not advice

Everything here comes from the U.S. Food and Drug Administration (FDA): the NDC Directory, Drugs@FDA, the official labels and recall reports; pharmacy costs come from the Centers for Medicare & Medicaid Services (CMS). Each fact shows its source and date.

This page is not medical advice. Talk to your doctor or pharmacist before you start, stop or switch any medicine, including a switch between a brand and a generic.

In an emergency, call 911. If someone may have taken too much of a medicine, call Poison Help: 1‑800‑222‑1222.

Quick answers

What is Axycis?
Axycis is a brand name of Cisplatin, a prescription medicine. The FDA NDC Directory lists 1 Axycis product in 1 strength and form.
Who makes Axycis?
Avyxa Holdings, LLC. holds the FDA application for Axycis (NDA220748, approved October 29, 2026).
Is there a generic or store brand of Axycis?
Yes. The FDA NDC Directory lists 12 other products with the same active ingredients, strength and form as a Axycis product, 9 of them generic. Ask your pharmacist whether one is right for you.
Has Axycis been recalled?
No recall linked to Axycis products (by their NDC code or label) appears in the FDA enforcement reports we use.

What Axycis is

Each Axycis product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.

Cisplatin · prescription medicine

Strength and formProduct namesSame medicine, other namesLabel
cisplatin 1 mg/mL
injection, solution (intravenous)
Axycis 12 products, 7 companies —

Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Cisplatin →

FDA approval

  • NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
FDA applications of Axycis products (Drugs@FDA)
ApplicationHolderFirst approvedProducts
NDA220748Avyxa Holdings, LLC.October 29, 20261

Companies that list Axycis

The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Axycis products.

Recalls

No recall linked to Axycis products (by their NDC code or label) appears in the FDA enforcement reports.

Next steps

Sources

  1. NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  2. Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  3. Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 13, 2026, retrieved November 14, 2026
  4. Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported November 10, 2026, retrieved November 14, 2026
  5. NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 11, 2026, retrieved November 14, 2026

Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.

Report an error → · Information for medicine makers